Poor sleep may be more than a symptom of exhaustion.
Bologna
Persistent insomnia may carry consequences that extend well beyond fatigue, irritability and difficulty concentrating. A scientific review involving more than 1.3 million people found that individuals with insomnia had a 26 percent higher risk of experiencing a stroke. The findings strengthen growing evidence that sleep disorders should be considered part of the broader conversation about neurological and cardiovascular health.
Researchers from the Istituto delle Scienze Neurologiche di Bologna examined nine studies addressing the relationship between insomnia and stroke, with six ultimately included in a meta-analysis covering 1,343,164 participants. The resulting risk ratio was 1.26, although the strength of the association varied among the studies. The researchers emphasized an important limitation: the analysis identifies an association, not proof that insomnia directly causes stroke.
The review also explored other health outcomes. Insomnia was associated with a 28 percent greater likelihood of hospitalization for any cause, based on data from more than half a million people. Previous evidence included in the review also linked insomnia with depression, suicidal behavior and several forms of cognitive deterioration. Associations with Alzheimer’s disease appeared more consistent than those involving vascular dementia, while the available evidence did not show a clear relationship with overall mortality.
Insomnia itself is more complex than occasionally sleeping badly. Clinically significant insomnia involves persistent difficulty falling asleep or remaining asleep despite having adequate conditions for rest, together with measurable effects on daytime functioning. Previous analyses estimate that roughly one in five adults may meet diagnostic criteria, making its potential population level consequences especially relevant.
Several biological mechanisms could help explain the association with stroke, although the review does not establish a single causal pathway. Chronic sleep disruption can coexist with hypertension, metabolic disorders, inflammation, stress and other conditions already associated with cerebrovascular risk. Medication use, lifestyle factors and differences in how insomnia was defined across individual studies further complicate interpretation.
The practical message is therefore not that one sleepless night predicts a stroke. The evidence instead suggests that persistent insomnia deserves clinical attention, particularly when it interferes with daily life or occurs alongside other cardiovascular risk factors.
Sleep is increasingly being recognized as an active component of brain health rather than simply a period of inactivity. When insomnia becomes chronic, ignoring it may mean overlooking a potentially important signal about the body’s wider state of health.
Truth is structure, not noise.